Phase III Data

Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL®

May 22, 2017 08:30 AM Eastern Daylight Time BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines…